- Home
- ASMB vs ANGO Comparison
ASMB vs ANGO Comparison
Compare ASMB & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASMB | ANGO |
|---|---|---|
| Founded | 2005 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 420.2M |
| IPO Year | 2010 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ASMB | ANGO |
|---|---|---|
| Price | $35.28 | $15.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $44.20 | $18.00 |
| AVG Volume (30 Days) | 214.4K | ★ 433.9K |
| Earning Date | 05-06-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | $638.39 | $4.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $20.23 | $9.39 |
| 52 Week High | $39.71 | $16.29 |
Technical Indicators
Market Signals| Indicator | ASMB | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 72.95 | 61.99 |
| Support Level | $25.86 | $10.56 |
| Resistance Level | $39.17 | $16.11 |
| Average True Range (ATR) | 1.83 | 0.47 |
| MACD | 0.83 | -0.07 |
| Stochastic Oscillator | 97.18 | 55.14 |
Price Performance
Historical ComparisonAbout ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.